First Light Asset Management LLC Has Trimmed Its Neogenomics INC (NEO) Position by $5.86 Million as Stock Price Rose

NeoGenomics, Inc. (NASDAQ:NEO) LogoInvestors sentiment increased to 2.07 in 2019 Q2. Its up 0.76, from 1.31 in 2019Q1. It improved, as 18 investors sold NEO shares while 49 reduced holdings. 43 funds opened positions while 96 raised stakes. 83.86 million shares or 10.48% more from 75.90 million shares in 2019Q1 were reported. Northwestern Mutual Wealth Management Comm holds 0% in NeoGenomics, Inc. (NASDAQ:NEO) or 5,633 shares. Employees Retirement Sys Of Texas owns 25,000 shares or 0.01% of their US portfolio. Moreover, Glenmede Na has 0.13% invested in NeoGenomics, Inc. (NASDAQ:NEO) for 1.30M shares. Jennison Assoc Limited accumulated 40,260 shares or 0% of the stock. Rhumbline Advisers reported 0.01% in NeoGenomics, Inc. (NASDAQ:NEO). First Light Asset Limited Co stated it has 4.04% in NeoGenomics, Inc. (NASDAQ:NEO). Balyasny Asset Ltd Liability reported 0.01% of its portfolio in NeoGenomics, Inc. (NASDAQ:NEO). Parametric Port Associates Ltd Liability Corporation reported 465,624 shares. Federated Invsts Pa reported 0.09% of its portfolio in NeoGenomics, Inc. (NASDAQ:NEO). Thrivent Financial For Lutherans accumulated 80,025 shares. Marshall Wace Ltd Liability Partnership holds 0.25% of its portfolio in NeoGenomics, Inc. (NASDAQ:NEO) for 1.36M shares. Optimum Advisors invested in 0% or 500 shares. Clarivest Asset Mngmt Ltd Liability Corporation has 112,679 shares for 0.05% of their portfolio. Loomis Sayles And LP owns 1.13 million shares for 0.05% of their portfolio. Charles Schwab Invest Mgmt holds 566,754 shares.

First Light Asset Management Llc decreased its stake in Neogenomics Inc (NEO) by 17.39% based on its latest 2019Q2 regulatory filing with the SEC. First Light Asset Management Llc sold 279,029 shares as the company’s stock rose 13.35% . The institutional investor held 1.33M shares of the health care company at the end of 2019Q2, valued at $29.08M, down from 1.60 million at the end of the previous reported quarter. First Light Asset Management Llc who had been investing in Neogenomics Inc for a number of months, seems to be less bullish one the $2.27B market cap company. The stock decreased 5.28% or $1.19 during the last trading session, reaching $21.36. About 922,541 shares traded or 9.87% up from the average. NeoGenomics, Inc. (NASDAQ:NEO) has risen 76.72% since September 13, 2018 and is uptrending. It has outperformed by 76.72% the S&P500.

First Light Asset Management Llc, which manages about $154.73 million and $720.22M US Long portfolio, upped its stake in Oxford Immunotec Global Plc (NASDAQ:OXFD) by 396,868 shares to 3.14 million shares, valued at $43.21 million in 2019Q2, according to the filing. It also increased its holding in Teva Pharmaceutical Ind (NYSE:TEVA) by 659,351 shares in the quarter, for a total of 972,234 shares, and has risen its stake in Myokardia Inc.

Analysts await NeoGenomics, Inc. (NASDAQ:NEO) to report earnings on October, 29. They expect $0.04 earnings per share, 0.00 % or $0.00 from last year’s $0.04 per share. NEO’s profit will be $4.26M for 133.50 P/E if the $0.04 EPS becomes a reality. After $0.05 actual earnings per share reported by NeoGenomics, Inc. for the previous quarter, Wall Street now forecasts -20.00 % negative EPS growth.

More notable recent NeoGenomics, Inc. (NASDAQ:NEO) news were published by: which released: “Here’s Why NeoGenomics Stock Rose 74% in the First Half of the Year – Nasdaq” on July 12, 2019, also with their article: “NeoGenomics (NEO) Earnings Expected to Grow: Should You Buy? – Nasdaq” published on July 23, 2019, published: “NeoGenomics (NEO) Hits Fresh High: Is There Still Room to Run? – Nasdaq” on May 03, 2019. More interesting news about NeoGenomics, Inc. (NASDAQ:NEO) were released by: and their article: “Garmin Unveils NEO 2T Smart to Sustain Fitness Momentum – Nasdaq” published on September 04, 2019 as well as‘s news article titled: “Stocks To Watch: Apple, IPOs And German Auto – Seeking Alpha” with publication date: September 07, 2019.

NeoGenomics, Inc. (NASDAQ:NEO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.